IMPROVED ALLOGRAFT SURVIVAL OF STRONG IMMUNE RESPONDER HIGH-RISK RECIPIENTS WITH ADJUVANT ANTI-THYMOCYTE GLOBULIN THERAPY

被引：52

作者：

KERMAN, RH ^{[1
]}

FLOYD, M ^{[1
]}

VANBUREN, CT ^{[1
]}

KAHAN, BD ^{[1
]}

机构：

[1] UNIV TEXAS,SCH MED,DEPT MED,DIV NEPHROL,HOUSTON,TX 77030

来源：

关键词：

D O I：

10.1097/00007890-198012000-00013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：450 / 454

页数：5

共 35 条

[1] HLA AND RENAL-TRANSPLANTATION
CARPENTER, CB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (15) : 860 - 862
[2] CARPENTER CB, 1979, TRANSPLANT P, V11, P1153
[3] CASCIANI CM, 1978, KIDNEY INT, V13, P49
[4] DANIELS JC, 1971, CLIN EXP IMMUNOL, V8, P213
[5] T-ROSETTE-FORMING CELLS, CELLULAR IMMUNITY AND CANCER
FUDENBERG, HH
WYBRAN, J
ROBBINS, D
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (09) : 475 - 476
[6] HERSH EM, 1977, CANCER COMPREHENSIVE, V6, P425
[7] HOLDSWORTH SR, 1978, CLIN EXP IMMUNOL, V33, P95
[8] HOY AT, 1978, J DIAL, V2, P1
[9] HUBER H, 1969, CLIN EXP IMMUNOL, V5, P75
[10] KAHAN BD, 1978, LEWIS PRACTICE SURGE, P1077